Remus Pharmaceuticals Limited (NSE:REMUS)
India · Delayed Price · Currency is INR 622.75
-36.80 (-5.58%)
Mar 16, 2026, 12:59 PM IST
Remus Pharmaceuticals Market Cap
Remus Pharmaceuticals has a market cap or net worth of 7.69 billion as of March 13, 2026. Its market cap has decreased by -32.27% in one year.
Market Cap
7.69B
Enterprise Value
7.95B
Revenue
7.48B
Ranking
n/a
PE Ratio
24.10
Stock Price
622.75
Market Cap Chart
Since May 29, 2023, Remus Pharmaceuticals's market cap has increased from 2.65B to 7.69B, an increase of 190.52%. That is a compound annual growth rate of 46.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 13, 2026 | 7.69B | -6.07% |
| Dec 31, 2025 | 8.19B | -44.37% |
| Dec 31, 2024 | 14.72B | 30.53% |
| Dec 29, 2023 | 11.27B | 325.95% |
| May 29, 2023 | 2.65B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Accent Microcell | 7.27B |
| Infinium Pharmachem | 3.17B |
| Quest Laboratories | 1.84B |
| Sotac Pharmaceuticals | 1.22B |
| Zenith Drugs | 707.39M |
| Vilin Bio Med | 447.80M |
| Medicamen Organics | 259.16M |
| Sunrest Lifescience | 184.09M |